Aitana Calvo

Encorafenib, Binimetinib, and Cetuximab in <i>BRAF</i> V600E–Mutated Colorectal Cancer

Scott Kopetz, Axel Grothey, Rona Yaeger et al. · New England Journal of Medicine · 2019 · 1.4K citations · Full text

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti–PD-1 for patients with anti–PD-1–refractory tumors

Iván Márquez‐Rodas, Federico Longo, María E. Rodríguez-Ruiz et al. · Science Translational Medicine · 2020 · 80 citations

Phase I/II study of LAG525 ± spartalizumab (PDR001) in patients (pts) with advanced malignancies.

David S. Hong, Patrick Schöffski, Aitana Calvo et al. · Journal of Clinical Oncology · 2018 · 69 citations

Phase I/ii Study, Immunology, Pathology +18

Effects of <i>Hypericum perforatum</i> on Ivabradine Pharmacokinetics in Healthy Volunteers: An Open‐Label, Pharmacokinetic Interaction Clinical Trial

Antonio Portolés, Ana Terleira, Aitana Calvo et al. · The Journal of Clinical Pharmacology · 2006 · 59 citations

Phase Ib/II study of lacnotuzumab (MCS110) combined with spartalizumab (PDR001) in patients (pts) with advanced tumors.

Aitana Calvo, Heikki Joensuu, Martin Sebastian et al. · Journal of Clinical Oncology · 2018 · 42 citations

Tumor-associated Macrophages, Breast Oncology, Antitumor Activity +16